>> Incidentally, authorized generics have been around for at least 10 years. <<
But they are essentially a loophole –I highly doubt that Congress intended to allow for their existence. Rather, Congress neglected to define “exclusivity” in sufficient detail in the portion of Hatch-Waxman dealing with 180-day generic exclusivity.
-- I’m hearing that EYET shares are all but impossible to borrow for shorting today. I’m glad I didn’t cover mine.
Market Data 
Markets 
AI
